{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T04:17:49Z","timestamp":1768709869158,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.ophtha.2007.03.012","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T08:26:40Z","timestamp":1180081600000},"page":"1248-1254.e2","source":"Crossref","is-referenced-by-count":42,"title":["Comparison of the Ocular Hypotensive Efficacy of Adjunctive Brimonidine 0.15% or Brinzolamide 1% in Combination with Travoprost 0.004%"],"prefix":"10.1016","volume":"114","author":[{"given":"Robert M.","family":"Feldman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo P.","family":"Tanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald L.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice Z.","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Prager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2007.03.012_bib1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.012_bib2","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0161-6420(01)00873-9","article-title":"Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery","volume":"108","author":"Lichter","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.03.012_bib3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The Advanced Glaucoma Intervention Study (AGIS): 7","volume":"130","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.012_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.121.1.48","article-title":"Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial","volume":"121","author":"Leske","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.012_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1185\/030079905X38222","article-title":"Intraocular pressure lowering effect of brinzolamide 1.0% as adjunctive therapy to latanoprost 0.005% in patients with open angle glaucoma or ocular hypertension: an uncontrolled, open-label study","volume":"21","author":"Shoji","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ophtha.2007.03.012_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/A:1006176713983","article-title":"Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressure","volume":"22","author":"Kimal Arici","year":"1998","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.012_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0002-9394(98)00155-X","article-title":"Combined effect of dorzolamide and latanoprost on the rate of aqueous humor flow","volume":"126","author":"Vanlandigham","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.012_bib8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0021-5155(03)00106-0","article-title":"A short-term study of the additive effect of latanoprost 0.005% and brimonidine 0.2%","volume":"47","author":"Erdogan","year":"2003","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.012_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00061198-200106000-00014","article-title":"Effectiveness and safety of brimonidine as adjunctive therapy for patients with elevated intraocular pressure in a large, open-label community trial","volume":"10","author":"Lee","year":"2001","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2007.03.012_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/archopht.117.5.573","article-title":"The Ocular Hypertension Treatment Study: design and baseline description of the participants","volume":"117","author":"Gordon","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.012_bib11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ophtha.2003.05.019","article-title":"Efficacy and safety of the fixed combinations latanoprost\/timolol versus dorzolamide\/timolol in patients with elevated intraocular pressure","volume":"111","author":"Shin","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.03.012_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00061198-200004000-00002","article-title":"Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma","volume":"9","author":"Asrani","year":"2000","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2007.03.012_bib13","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.ophtha.2004.02.017","article-title":"Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study","volume":"111","author":"Nouri-Mahdavi","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.03.012_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ophtha.2005.10.045","article-title":"Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension","volume":"113","author":"Orzalesi","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.03.012_bib15","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0002-9394(03)00098-9","article-title":"A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study","volume":"135","author":"Parrish","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.012_bib16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1089\/jop.2005.21.170","article-title":"The efficacy and safety of topical brinzolamide and dorzolamide when added to the combination therapy of latanoprost and a beta-blocker in patients with glaucoma","volume":"21","author":"Tsukamoto","year":"2005","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2007.03.012_bib17","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0002-9394(02)01418-6","article-title":"Additive intraocular pressure lowering effect of various medications with latanoprost","volume":"133","author":"O\u2019Connor","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.012_bib18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ophtha.2004.11.032","article-title":"24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects","volume":"112","author":"Konstas","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2007.03.012_bib19","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.clinthera.2006.04.007","article-title":"A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension","volume":"28","author":"Reis","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.ophtha.2007.03.012_bib20","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/bjo.2003.032979","article-title":"Brimonidine purite 0.15% versus dorzolamide 2% each given twice daily to reduce intraocular pressure in subjects with open angle glaucoma or ocular hypertension","volume":"88","author":"Sharpe","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2007.03.012_bib21","series-title":"Primary open-angle glaucoma. Preferred practice pattern","year":"2005"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642007002370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642007002370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T23:57:30Z","timestamp":1546819050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642007002370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0161642007002370"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2007.03.012","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}